CHERYL HUBBARD: Open Payments
NPI 1366915498 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 37 payments from 17 companies in 2025. Trend: 2023 $1,623 · 2024 $2,106 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $142 |
| ABBVIE INC. | 4 | $99 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Novo Nordisk Inc | 4 | $80 |
| Corium, LLC | 3 | $60 |
| Dexcom, Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $49 |
| Corcept Therapeutics | 2 | $49 |
| Exact Sciences Corporation | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: NURTEC ODT, VRAYLAR, TRELEGY ELLIPTA, Azstarys, Dexcom G6 Transmitter, MOUNJARO, Korlym, Wegovy.
Industry payments across AL — which companies pay providers there.
